Titlebook: Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis; Albert V. G. Bruschke,Johan H. C. Reiber,Hein J. J Book 1996 Kluwer Ac

极深

Impugn

mechanism

The St Thomas’ Atherosclerosis Regression Study and an appraisal of its potential limitationsoint blinded study of the effects of lipid-lowering therapy on angiographic coronary artery disease (CAD) in male patients with hypercholesterolemia. Both a fat-modified diet and diet-plus cholestyramine favourably influenced the course of CAD over 3 years. As discussed in this paper, the study did,

诗集

MAL

终点

Impact upon angiographic disease progression following step drug therapy in normolipidaemic patients potential benefit of drug therapy in normocholesterolaemic patients has not been examined in a randomized prospective fashion. Patients with symptomatic coronary artery disease with at least one lesion narrowed by >30% were randomized to either placebo (. = 39), or stepped drug therapy using pravas

happiness

L. Campeau,J. Lespérance,D. Waters,CCAIT Investigators

捕鲸鱼叉

MOTIF

Cleave